Point-of-care derived INR does not reliably detect significant coagulopathy following Australian snakebite
Authors:
- Elizabeth CorreljeECElizabeth Correlje
- Cameron L. MartinCMCameron L. Martin
- Jeremy D. RobertsonJRJeremy D. Robertson
- Geoffrey K. IsbisterGeoffrey K. Isbister
- 1 November 2013
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 132 (5) , 610-613
Abstract
No abstract availableKeywords
Funding Information
- NHMRC Clinical Career Development Fellowship (ID605817)
This publication has 14 references indexed in Scilit:
- A randomized controlled trial of fresh frozen plasma for treating venom‐induced consumption coagulopathy in cases of Australian snakebite (ASP‐18)Journal of Thrombosis and Haemostasis, 2013
- Clinical Effects and Antivenom Dosing in Brown Snake (Pseudonaja spp.) Envenoming — Australian Snakebite Project (ASP-14)PLOS ONE, 2012
- Factor deficiencies in venom‐induced consumption coagulopathy resulting from Australian elapid envenomation: Australian Snakebite Project (ASP‐10)Journal of Thrombosis and Haemostasis, 2010
- Changes in serial laboratory test results in snakebite patients: when can we safely exclude envenoming?Medical Journal of Australia, 2010
- Point‐of‐care testing in haemostasisBritish Journal of Haematology, 2010
- Development of a sensitive enzyme immunoassay for measuring taipan venom in serumToxicon, 2010
- Comparison of emergency department point-of-care international normalised ratio (INR) testing with laboratory-based testingEmergency Medicine Journal, 2010
- Procoagulant Snake Toxins: Laboratory Studies, Diagnosis, and Understanding Snakebite CoagulopathySeminars in Thrombosis and Hemostasis, 2009
- The Global Burden of Snakebite: A Literature Analysis and Modelling Based on Regional Estimates of Envenoming and DeathsPLOS Medicine, 2008
- Current use of Australian snake antivenoms and frequency of immediate‐type hypersensitivity reactions and anaphylaxisMedical Journal of Australia, 2008